Correlation Between Intel and Stoke Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intel and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Stoke Therapeutics, you can compare the effects of market volatilities on Intel and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Stoke Therapeutics.

Diversification Opportunities for Intel and Stoke Therapeutics

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Intel and Stoke is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Intel i.e., Intel and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between Intel and Stoke Therapeutics

Given the investment horizon of 90 days Intel is expected to generate 0.97 times more return on investment than Stoke Therapeutics. However, Intel is 1.03 times less risky than Stoke Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  3,010  in Intel on September 1, 2024 and sell it today you would lose (605.00) from holding Intel or give up 20.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Intel  vs.  Stoke Therapeutics

 Performance 
       Timeline  
Intel 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Intel exhibited solid returns over the last few months and may actually be approaching a breakup point.
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Intel and Stoke Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intel and Stoke Therapeutics

The main advantage of trading using opposite Intel and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.
The idea behind Intel and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm